BNET Industries

Igene Biotechnology Inc.

(IGNE) is in the Manufacturing Industry

Market Cap:$6.2M

Last Fiscal Year Sales:$7.6M

Public
US

Dow Jones Description

IGENE Biotechnology, Inc. ("Igene" or the "Company") was incorporated in the State of Maryland on October 27, 1981, to develop, produce and market value-added specialty biochemical products. Igene is a supplier of natural astaxanthin, an essential nutrient in different feed applications and a source of pigment for coloring farmed salmon species. Igene's natural astaxanthin product is marketed as AstaXin(R) and is made from yeast, and used as a source of pigment for coloring farmed salmonids. Igene is also venturing to supply astaxanthin as a nutraceutical ingredient. Igene is focused on research and development in the areas of fermentation technology, nutrition and health and the marketing of products and applications worldwide. Igene has devoted its resources to the development of proprietary processes to convert selected agricultural raw materials or feedstocks into commercially useful and cost effective products for the food, feed, flavor and agrochemical industries. In developing these processes and products, Igene has relied on the expertise and skills of its in-house scientific staff and, for special projects, various consultants.

President and Chief Technical Officer

Stephen F Hiu

Number of Employees 14

Contact Information

9110 Red Branch Rd

Suite J

Columbia, Maryland 21045-2024

igene.com

4109972599

Peer Companies

NAICS Code Pesticide and Other Agricultural Chemical Manufacturing: 325320

Executive Profiles

Decision Makers

Name (plus bio)	Position
Stephen F Hiu	President and Chief Technical Officer
Edward J Weisberger	Chief Financial Officer
Patrick F Monahan	V.P. and Director of Manufacturing
Robert Hodson	Vice President, Global Sales and Marketing
Michael G Kimelman	Director of Igene
Sidney R. Knafel	Director of Igene
Christine L Fitch	Office Manager
Claudio Gesche Montandon	Regional Manager
Malin Nilsson	Operating and Logistics Manager
James L Kempner	Director

Board of Directors

Name (plus bio)	Position
Thomas L. Kempner	Vice Chairman of the Board of Directors

Organization	Position	Status
Igene Biotechnology, Inc.	President and Chief Technical Officer	Current
Igene Biotechnology, Inc.	Treasurer	Current
Oregon State University	Ph.D. Degree In Microbiology	Former
University of California, Irvine	B.S. Degree In Biological Sciences	Former

Organization	Position	Status
Igene Biotechnology, Inc.	Chief Financial Officer	Current

Organization	Position	Status
Igene Biotechnology, Inc.	V.P. and Director of Manufacturing	Current
Igene Biotechnology, Inc.	Secretary	Current

Organization	Position	Status
Igene Biotechnology, Inc.	Vice President, Global Sales and Marketing	Current

MICHAEL G. KIMELMAN has served as a Director of Igene since February 1991 and as Chairman of the Board of Directors since March 1991. He is a founder and member of Kimelman & Baird, LLC, as well as Chairman of the Board of Directors of Astaxanthin Partners Ltd. He also serves on the Board and the Executive Committee of the Hambletonian Society.

Organization	Position	Status
Igene Biotechnology, Inc.	Director of Igene	Current
Igene Biotechnology, Inc.	Chairman of Board of Directors	Current
Baird, Inc.	Board of Directors	Former

SIDNEY R. KNAFEL has served as a director of Igene since 1982. He has also been Managing Partner of SRK Management Company, a private investment company located in New York City, since 1981 and has served as Chairman of Insight Communications, Inc. since 1985. Mr. Knafel is also currently a director of General American Investors Company, Inc. as well as a number of private companies.

Organization	Position	Status
Igene Biotechnology, Inc.	Director of Igene	Current
Iggyz.Com	Chairman	Current
Gen American Investors Company, Inc.	Chairman	Current
VirtualScopics, Inc.	Chairman of Insight Communications	Current
Insight Communications Company, Inc.	Chairman	Current
Gen American Investors Company, Inc.	Director	Current
Igene Biotechnology, Inc.	Board of Directors	Current
Srk	managing partner	Former
Insight, Inc.	Chairman	Former
Vocollect, Inc.	Director	Former
Insight Communications Company, Inc.	Director	Former
Harvard College	Graduate	Former
Harvard Business School	Graduate	Former

Organization	Position	Status
Igene Biotechnology, Inc.	Office Manager	Current

Organization	Position	Status
Igene Biotechnology, Inc.	Regional Manager	Current

Organization	Position	Status
Igene Biotechnology, Inc.	Operating and Logistics Manager	Current

James L. Kempner has served on our Board of Directors since August 2006. Mr. Kempner is a Managing Director at Lazard Freres & Co. LLC, which he joined in 1983, and was named a General Partner in 1993. Mr. Kempner has been involved in numerous banking and capital markets transactions, including advising Intersections on its initial public offering, and ran Lazard s Corporate Finance department from 1995-1998. Mr. Kempner serves on the Board of The New York Eye and Ear Infirmary and its Finance Committee. Mr. Kempner is the son of Thomas L. Kempner. Thomas L. Kempner has served on our Board of Directors since the inception of CreditComm, the predecessor to Intersections Inc. Mr. Kempner has been Chairman and Chief Executive Officer of Loeb Partners Corporation and its predecessors since 1979. Mr. Kempner is currently a director of Dyax Corporation, FuelCell Energy, Inc. and IGENE Biotechnology, Inc., and is currently a director emeritus at Northwest Airlines, Inc. Mr. Kempner is the father of James L. Kempner.

Organization	Position	Status
Loeb Partners Corporation	Chief Executive Officer	Current
Intersections Inc.	Managing Director at Lazard Freres	Current
Loeb Partners Corporation	Chairman	Current
CCP Equity Partners	Director	Current
FuelCell Energy, Inc.	Director	Current
Igene Biotechnology, Inc.	Director	Current
Intersections Inc.	Board of Directors	Current
Diversinet Corp.	Director	Current
Harvard University	M.B.A.	Former
Yale University	B.A.	Former

Organization	Position	Status
Pinpoint Partners	President	Current
Loeb Holding Corporation	President	Current
Intersections Inc.	Beneficial Owner	Current
Central Park Conservancy, Inc	Chairman (Click On Pdf to View Board List)	Current
FuelCell Energy, Inc.	Board of Directors	Current
Intersections Inc.	Director	Current
Insight Communications Company, Inc.	Director	Current
Diversinet Corp.	Director	Current
CCP Equity Partners	Director	Current
CCC Information Services, Inc.	Director	Current
Igene Biotechnology, Inc.	Vice Chairman of the Board of Directors	Current
Hereditary Angioedema	Board of Directors	Current
Igene Biotechnology, Inc.	Director	Current
Dyax Corp.	Director	Current
Wharton Investment Management Conference	Executive Managing Member, Davidson Kempner Capital Management	Current
Central Park Conservancy, Inc	Trustee	Current
Loeb Partners Corporation	Chief Executive Officer	Current
Hereditary Angioedema	Chairman and Chief Executive Officer, Loeb Partners Corporation	Former
First City Capital	Vice President	Former
Loeb Partners Corporation	Vice President	Former
Loeb Partners Corporation	Chairman	Current
Intermagnetics General Corporation	Director	Former
Northwest Airlines Corporation	Director	Former
Yale College		Former
Insight, Inc.	member	Former